The concept of innovative drugs continues to strengthen, with multiple stocks hitting the limit up.

The concept of innovative drugs continues to strengthen, with many individual stocks such as Nanjing Pharmaceutical, Aoxiang Pharmaceutical, Kangyuan Pharmaceutical, Qizheng Tibetan Medicine, Hanshang Group, Deyuan Health, and Loxin Pharmaceutical all hitting the daily limit up. Zhendong Pharmaceutical, Guangshengtang, and Tebao Biotech also saw significant gains.